Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.58 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.58 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.32 |
| ▸ | P2RX2 | Q9UBL9 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21542678 | 0.86 | GABRA1 (0.50) | GABRA1GABRB1GABRB2POLBGAA | |
| SCHEMBL28454010 | 0.79 | GABRA1 (0.58) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL461449 | 0.78 | CA1 (0.55) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL2155116 | 0.78 | ALDH1A1 (0.38) | GABRA1GABRB1GABRB2CA1CA2 | |
| Methane SCHEMBL27861345 | 0.76 | CA1 (0.52) | GABRA1GABRB1GABRB2CA1CA2 | |
| Hydrochloric Acid SCHEMBL5431425 | 0.76 | GAA (0.38) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL3440745 | 0.76 | GABRA1 (0.50) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL29926096 | 0.76 | CA1 (0.52) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL15082621 | 0.76 | GABRA1 (0.61) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL2735032 | 0.76 | NOS2 (0.43) | CA1CA2POLBGAAGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11976023-B1 | Synthetic route to 2,2',6,6'-tetraisopropyl-4,4'-diiodoazobenzene via homo-oxidative cross-coupling of aryl diazonium salt using cu-catalyzed sandmeyer-style reaction | King Faisal University (SA) | 2024-05-07 | — | — | US | claimed |
| CN-116554044-A | 2, 6-diisopropyl-4-carboxyaniline without amino protection and synthesis method thereof | 上海师范大学 | 2023-08-08 | — | — | CN | claimed |
| CN-110229080-A | Alpha-diimine nickel metal-organic solution deposition, porous organic polymer and its application | 山东师范大学 | 2019-09-13 | — | — | CN | claimed |
| US-20260002073-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2026-01-01 | — | — | US | disclosed |
| CN-119955072-A | Carbazole and carbene iridium difunctional super-crosslinked porous organic polymer and preparation method and application thereof | 浙江工业大学 | 2025-05-09 | — | — | CN | disclosed |
| EP-4527868-A2 | COMPOUND AND POLYMERIC COMPOUND INCLUDING SAID COMPOUND | Japan Science and Technology Agency (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2024247648-A1 | TUMOR THERAPEUTIC AGENT, AND COMPLEX | 学校法人兵庫医科大学 | 2024-12-05 | — | — | WO | disclosed |
| US-12145938-B2 | Compound and polymer compound containing the compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-11-19 | — | — | US | disclosed |
| US-12122918-B2 | Drug that reacts with acrolein, use thereof and novel compound | RIKEN (JP) | 2024-10-22 | — | — | US | disclosed |
| US-12075690-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2024-08-27 | — | — | US | disclosed |
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20210002284-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20210002284-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2021-01-07 | — | — | US | disclosed |
| CN-111788206-A | Compound and polymer compound containing the same | 国立研究开发法人科学技术振兴机构 | 2020-10-16 | — | — | CN | disclosed |
| CN-110229080-A | Alpha-diimine nickel metal-organic solution deposition, porous organic polymer and its application | 山东师范大学 | 2019-09-13 | — | — | CN | disclosed |
| WO-2019172200-A1 | COMPOUND AND POLYMERIC COMPOUND INCLUDING SAID COMPOUND | 国立研究開発法人科学技術振興機構 | 2019-09-12 | — | — | WO | disclosed |
| US-20190189935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-06-20 | — | — | US | disclosed |
| US-20190189935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-06-20 | — | — | US | disclosed |
| US-6664408-B2 | Contacting a polyoxometalate and an amine in the presence of a diimide | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2003-12-16 | — | — | US | disclosed |
| US-20020165405-A1 | Process for preparing organically-substituted polyoxometalates | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2002-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165405-A1 | Process for preparing organically-substituted polyoxometalates | TET2, ALKBH3, FTO | GABRA1 1608/4885GABRB1 2457/4885GABRB2 2704/4885 |
| US-20190189935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OR10J3, OXER1, CHRM4 | GABRA1 3050/4885GABRB1 3350/4885GABRB2 3618/4885 |
| US-20260002073-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OPRD1, OR10J3 | GABRA1 2657/4885GABRB1 1939/4885GABRB2 2577/4885 |
| US-11976023-B1 | Synthetic route to 2,2',6,6'-tetraisopropyl-4,4'-diiodoazobenzene via homo-oxidative cross-coupling of aryl diazonium salt using cu-catalyzed sandmeyer-style reaction | CYP4Z1, SOD1, AOC2 | GABRA1 1640/4885GABRB1 524/4885GABRB2 391/4885 |
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | RAD51, MDM2, UBE2D3 | GABRA1 4768/4885GABRB1 4804/4885GABRB2 4807/4885 |
| US-12145938-B2 | Compound and polymer compound containing the compound | RAD51, MDM2, UBE2D3 | GABRA1 4768/4885GABRB1 4804/4885GABRB2 4807/4885 |
| US-12122918-B2 | Drug that reacts with acrolein, use thereof and novel compound | ACR, CYP2E1, CES2 | GABRA1 718/4885GABRB1 1188/4885GABRB2 1696/4885 |
| US-12075690-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRM1 | GABRA1 3877/4885GABRB1 4222/4885GABRB2 4121/4885 |
| US-20210002284-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | RAD51, MDM2, UBE2D3 | GABRA1 4765/4885GABRB1 4805/4885GABRB2 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.